Eogan 2007.
Study characteristics | ||
Methods | Study design: randomised controlled trial Trial duration: 12 months (May 2003 to April 2004) Trial location: National Maternity Hospital, Holles St Dublin, Ireland |
|
Participants | Participants: 147 postpartum women with sphincter injury at vaginal delivery, undergoing primary repair of a recognised anal sphincter tear Intervention group: 70 postpartum women Control group: 77 postpartum women Exclusion criteria: history of colorectal disease, inflammatory bowel disease, diabetes mellitus, or colorectal malignancy |
|
Interventions | Intervention: oral lactulose 10 mL thrice daily for the first 3 postpartum days, followed by sufficient lactulose to maintain a soft stool for 10 days, plus 1 sachet of Ispaghula husk for 10 days Control: oral lactulose 10 mL thrice daily for the first 3 postpartum days, followed by sufficient lactulose to maintain a soft stool for 10 days All women were given routine antibiotics (co‐amoxyclavulanic acid); erythromycin and metronidazole were used in those with penicillin allergy All participants were provided with a diary card to keep record of their bowel habits and movements for 10 days Opiate was avoided in both groups |
|
Outcomes |
Primary outcomes 1. Discomfort with 1st postpartum bowel motion (using pain scale from 1 = no pain to 5 = excruciating pain) 2. Incidence of postnatal constipation and incontinence Secondary outcomes 1. Time until first bowel motion 2. Duration of postnatal stay 3. Symptomatic and functional outcomes 3 months postpartum All participants were provided with a diary card to keep record of their bowel habits and movements for 10 days; opiate was avoided in both groups |
|
Notes | Funding: the study was supported by the Irish Health research board Correspondence: email was sent to the author (colm.oherlihy@ucd.ie) requesting further information on method used to ensure adequate concealment of the assignment and blinding processes, but there was no response. Dates of study: the study was conducted between May 2003 and April 2004 Funding sources: the study was supported by the Irish Health research board Declarations of interest: not disclosed |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Randomisation was carried out using computer‐generated allocations. |
Allocation concealment (selection bias) | Unclear risk | ''Sealed opaque envelopes were used to concealed allocation identity''. It was not specified whether the envelopes were sequentially numbered to prevent selection bias. |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | There was no explicit information on blinding of the participants, personnel, and investigators to the assignment. |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Insufficient information to judge whether the assessors were blinded to the assignment or not |
Incomplete outcome data (attrition bias) All outcomes | High risk | All participants attended the first 10 day follow‐up; 26 did not attend postpartum review at 3 months despite 2 repeated appointment‐reminders being sent, 24 of whom gave a personal reason and 2 could not be traced Attrition rate in intervention group (LG) = 16% Attrition rate in control group (FG) = 20% |
Selective reporting (reporting bias) | Low risk | All outcomes that were prespecified in the methods were addressed. |
Other bias | Low risk | The study appeared to be free of other sources of bias. |